HCPCS Code Details - J2779

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J2779
Description

Long description:
Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

Short description:
Inj, susvimo 0.1 mg

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code A - Add procedure or modifier code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2022
Date added Added Jul 01, 2022
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J2779

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
Jul 1, 2022 - Sep 30, 2022 0.1 MG 83.229 - - - - - -

See also

  • HCPCS J2778 · Injection, ranibizumab, 0.1 mg

  • HCPCS C9093 · Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg

  • HCPCS J2780 · Injection, ranitidine hydrochloride, 25 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”